Prognosis factors and risk-adapted therapy of Hodgkin lymphoma / 白血病·淋巴瘤
Bian WEI; Huaqing WANG; Zhi CHANG; Yang ZHENG.
Journal of Leukemia & Lymphoma
; (12): 385-388, 2020.
Artículo
en Zh
| WPRIM | ID: wpr-862859
Hodgkin lymphoma (HL) is a kind of malignant lymphoma with a good prognosis. With the constant development of medical technology, the cure rate of HL has increased significantly. At present, the main problem is risk-adapted therapy according to the disease condition and prognosis-related factors to increase or decrease the intensity of treatment, in order to increase the cure rate and reduce the side effects, prolong the survival time and improve the quality of life of patients. This article focuses on the analysis of HL prognosis-related factors, common treatment methods for HL, and the effect of PET-CT results on the implementation of risk-adapted therapy.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados